Zimmer biomet holdings inc

US StockHealth Care

ZBH AI Analysis Overview

Keys for Bullish View

  • Value≥4
  • Dividend≥2

Analysis Conclusion

The stock has received the highest rating for its value, and its dividend score is solid. It's ideal for long-term position building. For optimal entry, check our trend or swing trading rating.

ZBH Current Performance

0.50%

Zimmer biomet holdings inc

0.68%

Avg of Sector

0.03%

S&P500

Top 10 High Relevance to ZBH

  • SYK Stryker corporation
    Value 3Trend 5Swing Trading 4Whale Interest 3Dividend 4
    See more

ZBH Profile

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.

Price of ZBH